C0278983||Stage IIIA Non-Small-Cell Lung Cancer
C0436307||Chemoradiotherapy
C0278983||stage IIIA non-small-cell lung cancer
C0278983||non-small-cell lung cancer
C0600558||neoadjuvant
C3178775||concurrent chemoradiotherapy
C3178775||concurrent chemoradiotherapy
C1519810||unresectable
C2603343||study
C0040808||phased CCRT protocol
C0278983||stage IIIA NSCLC
C3178775||continuous-course definitive CCRT
C0278983||stage IIIA NSCLC
C3178775||concurrent chemoradiotherapy
C0040808||phased CCRT protocol
C0600558||neoadjuvant
C3178775||concurrent chemoradiotherapy
C0481504||maintenance chemotherapy
C3178775||split-course CCRT
C3178775||continuous-course definitive CCRT
C0936012||analyzed
C1522577||follow-up
C1518965||performance status
C0001418||adenocarcinoma
C1514474||independent prognostic factors
C0278983||stage IIIA NSCLC
C0040808||phased CCRT strategy
C3178775||split-course CCRT
C0481504||maintenance chemotherapy